# OnCo record mark-litzow (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/mark-litzow/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "mark-litzow" ;
  schema:name "Mark R. Litzow"@en ;
  schema:description "Leukaemia specialist who led E1910, the trial that put blinatumomab into frontline treatment for adults in remission."@en ;
  schema:url <https://onco.cc/people/mark-litzow/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.mayo.edu/research/faculty>, <https://pubmed.ncbi.nlm.nih.gov/?term=Litzow%20MR%5BAuthor%5D>, <https://scholar.google.com/scholar?q=Mark%20R.%20Litzow> ;
  schema:jobTitle "Professor of Medicine, Mayo Clinic; Chair, ECOG-ACRIN Leukemia Committee; Study Chair, E1910" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/> ;
  onco:targets <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/cd3/> ;
  onco:drugs <https://onco.cc/drugs/blinatumomab/> ;
  onco:companies <https://onco.cc/companies/ecog-acrin/> ;
  onco:institutions <https://onco.cc/institutions/mayo-clinic/> ;
  onco:trials <https://onco.cc/trials/e1910/> ;
  schema:affiliation <https://onco.cc/institutions/mayo-clinic/> .